ATC code - L01EB02
PolandErlotinib
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 27.32 mg ATC code: L01EB02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o.
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 109.27 mg ATC code: L01EB02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o.
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 163.9 mg ATC code: L01EB02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o.
-
Form: tablets, film-coated
Active substance Dosage erlotinib 25 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
Form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
Form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
Form: tablets, film-coated
Active substance Dosage erlotinib 25 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
Form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
Form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.